The ruling was a milestone in yearslong efforts to make the OxyContin manufacturer pay for its role in the opioid crisis, but some plaintiffs feel the plan doesn’t go far enough.
Mr. Hanly had been central to the current nationwide litigation against pharmaceutical companies, pharmacies and others in the opioid supply chain.
Five articles from around The Times, narrated just for you.
A decade ago, it was already a crisis. But it feels like its getting worse.
Patrick Radden Keefe’s new book is about the Sacklers, the family whose company created the powerful painkiller that ushered in a new era of both pain management and opioid addiction.
The OxyContin maker filed its long-awaited restructuring plan in bankruptcy court. Revenue from the new company would go exclusively to abating the opioid crisis.
The prosecution on Long Island is one of several across the nation that seek to hold doctors criminally accountable for opioid-related deaths.
Partners decided not to keep Kevin Sneader in the top job. Weeks earlier, McKinsey had reached a historic settlement agreement in the U.S. over its advice to drugmakers.
One activist is asking the Biden administration to remember the failures that led to the opioid epidemic as it chooses the next head of the F.D.A.
The consulting firm has reached the agreement with 47 states because of its advice to drugmakers, including Purdue Pharma, the manufacturer of OxyContin.
It was the first time in years that members of the family that owns Purdue Pharma have taken questions publicly, and the exchanges were tense.
The firm faced criticism after a report revealed that consultants had discussed destroying documents related to the opioid business and proposed that a drugmaker pay its distributors rebates for overdoses.
A trapdoor in the Justice Department deal with the family’s company might enable them to escape a full accounting of their part in the opioid epidemic.
Parents should not be afraid of managing the child’s pain with opioids when they are needed, but should make sure a child does not have access to leftover doses.
Court filings reveal consultants’ talk of a records purge during the opioid crisis, and shed new light on sales advice given to the billionaire Sackler family and their drug company, Purdue Pharma.
The admission in federal court brought a formal end to a major investigation that resulted in a multibillion-dollar settlement between the drug maker and the government.
Three distributors and a drug manufacturer have proposed a deal that a majority of states and negotiators for small governments finally seem to like.
The company, which produced OxyContin, faces penalties of $8.3 billion. But families of those addicted are skeptical of the tangible benefits.
The Justice Department announced an $8 billion settlement with the company. Members of the Sackler family will pay $225 million in civil penalties but criminal investigations continue.
In a family plagued by addiction, I was determined to help my teen recover from surgery without opiates.
Tyler Skaggs, who had fentanyl and oxycodone in his system at the time of his death, would not have died if not for the fentanyl, federal prosecutors said on Friday.
The family behind Purdue Pharma made a fortune on the opioid epidemic. Will they ever truly face justice?
New details emerge in a lawsuit asserting that chains including CVS, Rite Aid and Walgreens sold millions of pills in small towns but rarely flagged suspicious orders to authorities.